Scholar Rock Stock Jumps As Rival Biohavens Muscle-Wasting Drug Flunks Pivotal Study
| SRRK Stock | USD 38.15 1.09 2.94% |
About 54% of Scholar Rock's institutional investors are presently thinking to get in. The analysis of the overall investor sentiment regarding Scholar Rock Holding suggests that some traders are interested. Scholar Rock's investing sentiment shows overall attitude of investors towards Scholar Rock Holding.
Scholar |
Biohaven reported taldefgrobep data showing motor function gains in SMA and plans to advance obesity studies with an autoinjector in 4Q24.
Read at benzinga.com
 |
Scholar Rock Fundamental Analysis
We analyze Scholar Rock's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Scholar Rock using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Scholar Rock based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Book Value Per Share
Book Value Per Share Comparative Analysis
Scholar Rock is currently under evaluation in book value per share category among its peers. Book Value per Share (B/S) can be calculated by subtracting liabilities from assets, and then dividing it by the total number of currently outstanding shares. It indicates the level of safety associated with each common share after removing the effects of liabilities. In other words, a shareholder can use this ratio to see how much he or she can sell the stake in the company in the event of a liquidation.
Scholar Rock Holding Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Scholar Rock stock to make a market-neutral strategy. Peer analysis of Scholar Rock could also be used in its relative valuation, which is a method of valuing Scholar Rock by comparing valuation metrics with similar companies.
Peers
Scholar Rock Related Equities
| PASG | Passage Bio | 20.97 | ||||
| IGMS | IGM Biosciences | 10.25 | ||||
| ARVN | Arvinas | 6.13 | ||||
| GLUE | Monte Rosa | 5.93 | ||||
| MLYS | Mineralys Therapeutics, | 4.71 | ||||
| BDTX | Black Diamond | 4.05 | ||||
| CGEM | Cullinan Oncology | 2.51 | ||||
| MGTX | MeiraGTx Holdings | 2.50 | ||||
| KROS | Keros Therapeutics | 2.02 | ||||
| PLRX | Pliant Therapeutics | 1.42 | ||||
| STOK | Stoke Therapeutics | 1.19 | ||||
| RLAY | Relay Therapeutics | 0.84 | ||||
| IDYA | Ideaya Biosciences | 0.78 | ||||
| HOWL | Werewolf Therapeutics | 0.51 | ||||
| RVMD | Revolution Medicines | 0.09 | ||||
| ANAB | AnaptysBio | 0.51 | ||||
| RNA | Avidity Biosciences | 1.07 | ||||
| IKNA | Ikena Oncology | 1.17 | ||||
| DSGN | Design Therapeutics | 2.93 |
Check out Scholar Rock Hype Analysis, Scholar Rock Correlation and Scholar Rock Performance. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Scholar Rock. If investors know Scholar will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Scholar Rock listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Scholar Rock Holding is measured differently than its book value, which is the value of Scholar that is recorded on the company's balance sheet. Investors also form their own opinion of Scholar Rock's value that differs from its market value or its book value, called intrinsic value, which is Scholar Rock's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Scholar Rock's market value can be influenced by many factors that don't directly affect Scholar Rock's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Scholar Rock's value and its price as these two are different measures arrived at by different means. Investors typically determine if Scholar Rock is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Scholar Rock's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.